Overview
Alexandre Fontayne practices practicing medicine in Lille, France.
His clinical expertise encompasses Botulism, Hemophilia A, Ovarian Cancer, and Blood Clots.
He is actively involved in clinical research, co-authoring 15 peer reviewed articles.
Gender
Locations
Pas-en-artois, France
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Alexandre Fontayne
Is Alexandre Fontayne a top-rated expert for Botulism?
MediFind is an objective health platform that identifies experts based on real-world data. Alexandre Fontayne is classified as an Experienced expert for Botulism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Alexandre Fontayne participate in research or clinical trials?
Yes. Alexandre Fontayne has published 15 articles and abstracts on conditions like Botulism. You can view a list of Alexandre Fontayne's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Blood ClotsMr. Fontayne isExperienced. Learn about Blood Clots.
- BotulismMr. Fontayne isExperienced. Learn about Botulism.
- Hemophilia AMr. Fontayne isExperienced. Learn about Hemophilia A.
- Ovarian CancerMr. Fontayne isExperienced. Learn about Ovarian Cancer.